drugset / Trial / NCT00473070

A Clinical Study of Tobradex AF

NCT00473070 ↗

Phase 3 Completed 900 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Timeline

Start
2006-11
Primary completion
2007-02
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Tobradex AF Unknown — —

Indications